2024. An LC-MS/MS Method Development and Validation for the Quantification of Infigratinib in K2EDTA Human Plasma. International Journal of Pharmaceutical Sciences and Drug Research. 16, 1 (Jan. 2024), 86–91. DOI:https://doi.org/10.25004/IJPSDR.2024.160112.